Synapse

← Skin Health and Disease

Papers in Skin Health and Disease

Page 1 · newest first

  1. Assessing the content validity of the 2015 core domain set for vitiligo clinical trials: preliminary investigations for developing an updated versionSkin Health and Disease · 2026
  2. A fluorescence-based reporter system to monitor human papillomavirus E2-dependent reporter activation in keratinocytesSkin Health and Disease · 2026
  3. Association of red cell distribution width with disease activity and antidesmoglein antibody levels in pemphigus vulgaris: a prospective case–control studySkin Health and Disease · 2026
  4. Mismatch repair protein deficiency in sebaceous neoplasms and its associations: a two-centre retrospective analysis in IranSkin Health and Disease · 2026
  5. Neurological adverse events of ivermectin: a retrospective pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) databaseSkin Health and Disease · 2026
  6. Pilomatrixomas: syndromic associations and a guide to germline genetic testingSkin Health and Disease · 2026
  7. Does avoidance of oral exposure to patch test allergens benefit patients with eczema? A systematic reviewSkin Health and Disease · 2026
  8. Eosinophils and eosinophilic skin diseases: a narrative reviewSkin Health and Disease · 2026
  9. Beyond the surface: pseudoxanthoma elasticum in skin of colourSkin Health and Disease · 2026
  10. A case of verrucous venous malformation and challenges associated with treatmentSkin Health and Disease · 2026
  11. Polymorphous immunotherapy-induced cutaneous sarcoidosisSkin Health and Disease · 2026
  12. A systematic review of the clearance and recurrence rate of recalcitrant warts following bleomycin treatmentSkin Health and Disease · 2026
  13. Inequality and determinants of access to phototherapy among patients with psoriasis in ThailandSkin Health and Disease · 2026
  14. Machine learning applications in androgenetic alopecia: a systematic reviewSkin Health and Disease · 2026
  15. Prevalence and determinants of anxiety and depression in adult patients with atopic dermatitis in TanzaniaSkin Health and Disease · 2026
  16. Anti-Ro52-positive antisynthetase syndrome mimicking tuberculosis in a high-burden setting: a delayed diagnosis with therapeutic successSkin Health and Disease · 2026
  17. Beyond diagnostic accuracy: evaluating the clinical utility of artificial intelligence for suspicious lesion triageSkin Health and Disease · 2026
  18. Rapidly growing well-differentiated cutaneous squamous cell carcinoma of the scalp in a patient who was immunosuppressedSkin Health and Disease · 2026
  19. Improving undergraduate teaching of chronic wounds with three-dimensional silicone models: a Finnish questionnaire-based cohort studySkin Health and Disease · 2026
  20. A single-centre, retrospective cohort study of paediatric tinea capitis in the United KingdomSkin Health and Disease · 2026
  21. Efficacy and safety of two interleukin-17 inhibitors (bimekizumab and secukinumab) in the management of hidradenitis suppurativa: a systematic review and meta-analysis of randomized controlled trialsSkin Health and Disease · 2026
  22. Guselkumab as a therapeutic option for recalcitrant pyoderma gangrenosum and Crohn disease: a case report and review of the literatureSkin Health and Disease · 2026
  23. Efficacy and safety of spesolimab in resistant pyoderma gangrenosum: a case report and brief review of the literatureSkin Health and Disease · 2026
  24. Racial and ethnic disparities in T helper 2-mediated inflammatory skin disordersSkin Health and Disease · 2026
  25. ‘My HS is significantly impacted by my cycle’: a cross-sectional study exploring the impact of menstruation and pregnancy on hidradenitis suppurativaSkin Health and Disease · 2026
  26. Novel cutaneous adverse effects of the increasingly prevalent glucagon-like peptide 1 agonistsSkin Health and Disease · 2026
  27. A case of bilateral upper limb eczema herpeticumSkin Health and Disease · 2026
  28. Clinical trial exit interviews in patients with moderate-to-severe chronic hand eczema: perspectives on disease burden and treatment experiences with delgocitinib cream in the phase III DELTA 1 trialSkin Health and Disease · 2026
  29. Identifying and addressing obstacles to optimal alopecia areata and atopic dermatitis care in the UKSkin Health and Disease · 2026
  30. Evaluating serum procollagen type III N-terminal peptide use as a liver fibrosis screening test in patients with psoriasis receiving methotrexate: a retrospective service evaluation in comparison with the Fibrosis-4 (FIB-4) indexSkin Health and Disease · 2026
  31. Atypical Spitz tumours across age groups: clinicopathological features, management strategies and long-term outcomes in a 20-year retrospective cohort studySkin Health and Disease · 2026
  32. Enhanced in vivo thromboxane biosynthesis in melanoma compared with basal cell carcinoma skin cancersSkin Health and Disease · 2026
  33. Performance of the ‘DermDx’ algorithm in triaging suspected skin cancers: results of the AI-SCSS studySkin Health and Disease · 2026
  34. Socioeconomic factors and time to diagnosis in hidradenitis suppurativaSkin Health and Disease · 2026
  35. Progressive isolated lower-lip oedema after mRNA COVID-19 booster complicated by methicillin-resistant Staphylococcus aureus superinfection: a necrotizing fasciitis mimicSkin Health and Disease · 2026
  36. Comparison of narrowband ultraviolet B with psoralen plus ultraviolet A phototherapy for patients with early-stage mycosis fungoides: a systematic review and meta-analysisSkin Health and Disease · 2026
  37. Guselkumab treatment of psoriasis results in sustained reduction of systemic inflammatory biomarkers to week 48 in three phase III randomized controlled trialsSkin Health and Disease · 2026
  38. Healthcare resource use, costs and health-related quality of life in the UK–Irish Atopic eczema Systemic Therapy Register (A-STAR): a pilot studySkin Health and Disease · 2026
  39. Immunological aspects and quality of life among patients with lichen sclerosusSkin Health and Disease · 2026
  40. A survey of topical treatment adherence and self-compassion in people living with psoriasisSkin Health and Disease · 2026
  41. A new association of cutaneous leishmaniasis with guselkumab in a patient with chronic psoriasisSkin Health and Disease · 2026
  42. Psychodermatology in Ireland: current practices, confidence and barriers among dermatologistsSkin Health and Disease · 2026
  43. Factors associated with prolonged hospital stay in patients with autoimmune bullous diseases treated at an in-patient dermatology serviceSkin Health and Disease · 2026
  44. A middle-aged man with progressive facial swelling and generalized violaceous plaquesSkin Health and Disease · 2026
  45. Living with cutaneous porphyria: findings from a qualitative survey studySkin Health and Disease · 2026
  46. Efficacy and safety of topical statins for porokeratosis: a systematic review and practice-guided synthesisSkin Health and Disease · 2026
  47. Living with melanoma: a study protocol for the design and participatory development of a survivorship care programme for people with metastatic melanomaSkin Health and Disease · 2026
  48. Skin cancer prevention practices of barbers for their customers: a pilot studySkin Health and Disease · 2026
  49. Narrowband ultraviolet B and psoralen plus ultraviolet A phototherapy treatment for mycosis fungoides: a 17-year retrospective cohort study in a university teaching hospital, 2007–24Skin Health and Disease · 2026
  50. ALADIN (Acne Lesion And Density INdex): a novel tool for automatic acne severity assessmentSkin Health and Disease · 2026